MEDICAL USES, METHODS AND USES

escribed are agents which inhibit microRNA-144 (miR-144) for use in treating or preventing a liver disease and/or liver condition in which oxidative stress is a contributory factor in a subject, methods for identifying a subject who has, or who is at risk of developing, said liver disease and/or liver condition, methods of predicting the response of a subject with said liver disease and/or liver condition to an agent which inhibits miR-144, methods of diagnosing said liver disease and/or liver condition, pharmaceutical compositions and kits.